GFAP and amyloidosis: When delineated by amyloid status, plasma p-tau181 and GFAP were key predictors in the Aβ+ decline model (n = 79) while plasma Aβ42/Aβ40 was the top plasma predictor in both models (Aβ− n = 289) (Fig. 5).